Contenido para descargar

¿Cuánto sabemos de biosimilares?

Novel Management and Screening Approaches for Haematological Complications of Gaucher’s disease

Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment

Scoring system to facilitate diagnosis of Gaucher disease

Gaucher Disease: New Expanded Classification Emphasizing Neurological Features

The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher disease

The road to biosimilars in rare diseases - ongoing lessonsfrom Gaucher disease

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

A reappraisal of Gaucher disease-diagnosis and disease management algorithms

Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia

A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China

Gaucher disease and SARS-CoV-2 infection: Emerging management challenges

Understanding the natural history of Gaucher disease

Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry

The European Gaucher Alliance: a survey of member patient organisations’ activities, healthcare environments and concerns

Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists